83 related articles for article (PubMed ID: 28627122)
1. A biotinylated peptide, BP21, as a novel potent anti-anaphylactic agent targeting platelet-activating factor.
Sato A; Ebina K
J Pept Sci; 2017 Sep; 23(9):727-735. PubMed ID: 28627122
[TBL] [Abstract][Full Text] [Related]
2. A biotinylated peptide, BP21, alleviates hypotension in anaphylactic mice.
Sato A; Ebina K
J Pept Sci; 2019 Aug; 25(8):e3197. PubMed ID: 31264321
[TBL] [Abstract][Full Text] [Related]
3. Biotinylated peptides substituted with D-amino acids with high stability as anti-anaphylactic agents targeting platelet-activating factor.
Sato A; Fukase T; Ebina K
J Pept Sci; 2022 Oct; 28(10):e3412. PubMed ID: 35437860
[TBL] [Abstract][Full Text] [Related]
4. An endothelin-3-related synthetic biotinylated pentapeptide as a novel inhibitor of platelet-activating factor.
Sato A; Suzuki T; Oikawa K; Ohta R; Ebina K
Eur J Pharmacol; 2013 Aug; 714(1-3):142-7. PubMed ID: 23792041
[TBL] [Abstract][Full Text] [Related]
5. Biotinylated heptapeptides substituted with a D-amino acid as platelet-activating factor inhibitors.
Sato A; Yokoyama I; Ebina K
Eur J Pharmacol; 2015 Oct; 764():202-207. PubMed ID: 26142829
[TBL] [Abstract][Full Text] [Related]
6. Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor.
Sato A; Kumagai T; Aoki J; Ebina K
Eur J Pharmacol; 2012 Jun; 685(1-3):205-12. PubMed ID: 22542654
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats.
Sato A; Yokoyama I; Ebina K
Peptides; 2015 Nov; 73():60-6. PubMed ID: 26348270
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
Arimura A; Harada M
Lipids; 1991 Dec; 26(12):1386-90. PubMed ID: 1819738
[TBL] [Abstract][Full Text] [Related]
9. A synthetic biotinylated peptide, BP21, inhibits the induction of mRNA expression of inflammatory substances by oxidized- and lyso-phosphatidylcholine.
Sato A; Kumagai T; Ebina K
Drug Dev Res; 2014 Jun; 75(4):246-56. PubMed ID: 24890951
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
11. The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB/c mice.
Wang M; Shibamoto T; Kuda Y; Tanida M; Zhang T; Song J; Kurata Y
Life Sci; 2016 Feb; 147():77-84. PubMed ID: 26808090
[TBL] [Abstract][Full Text] [Related]
12. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor in the inflammatory exudate in the anaphylactic phase of allergic inflammation in rats.
Watanabe M; Ohuchi K; Sugidachi A; Hirasawa N; Hayashi Y; Tsurufuji S
Int Arch Allergy Appl Immunol; 1987; 84(4):396-403. PubMed ID: 3119503
[TBL] [Abstract][Full Text] [Related]
14. A lethal role of platelet activating factor in anaphylactic shock in mice.
Terashita Z; Imura Y; Shino A; Nishikawa K
J Pharmacol Exp Ther; 1987 Oct; 243(1):378-83. PubMed ID: 3118009
[TBL] [Abstract][Full Text] [Related]
15. Synthetic biotinylated peptide compound, BP21, specifically recognizes lysophosphatidylcholine micelles.
Sato A; Aoki J; Ebina K
Chem Biol Drug Des; 2012 Sep; 80(3):417-25. PubMed ID: 22591064
[TBL] [Abstract][Full Text] [Related]
16. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
17. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
[TBL] [Abstract][Full Text] [Related]
18. Common mechanism in endothelin-3 and PAF receptor function for anti-inflammatory responses.
Sato A; Ebina K
Eur J Pharmacol; 2013 Oct; 718(1-3):30-3. PubMed ID: 24055926
[TBL] [Abstract][Full Text] [Related]
19. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
20. Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear.
Inagaki N; Miura T; Ohira K; Nagai H; Xu QA; Koda A
J Pharmacobiodyn; 1990 May; 13(5):272-7. PubMed ID: 2177106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
